| Gene symbol | IL2 | Synonyms | IL-2, TCGF, lymphokine | Type of gene | protein-coding |
| Chromosome | 4 | Map location | 4q27 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | interleukin 2 | ||||
| GTO ID | GTC1206 |
| Trial ID | NCT00062036 |
| Disease | Melanoma |
| Altered gene | IL-2 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | IL-2 RV tumor cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Completed |
| Title | Tumor Infiltrating Lymphocytes (TIL Cells) Transduced With An Interleukin-2 (SBIL-2) Gene Following The Administration Of A Nonmyeloablative But Lymphocyte Depleting Regimen in Metastatic Melanoma |
| Year | 2003 |
| Country | United States |
| Company sponsor | National Institutes of Health Clinical Center |
| Other ID(s) | 030162|03-C-0162|NCI-5855|CDR0000304438 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||